Debra Barker has been named chief medical officer at Centauri Therapeutics, bringing extensive experience in clinical immunology. She will be responsible for advancing the company's therapeutic development pipelines and overseeing the progression of their lead candidate through clinical trials.
Who to call at Centaurus Therapeutics, and when
A new leader at Centaurus Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Centaurus Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Centaurus Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Centaurus Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Centaurus Therapeutics
Location
London, England, United Kingdom
About
Centauri Therapeutics Limited is a UK-based biotechnology company developing novel treatments for life-threatening diseases using its proprietary Alphamer technology. This approach harnesses "programmable immunity" by redirecting natural antibodies to target pathogens, using molecules that bind to pathogens and present epitopes to trigger an immune response. Backed by strong IP and a portfolio of patents, Centauri is advancing specific leads with the potential to deliver fast, targeted antibacterial therapies.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Centaurus Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LondonOtherBiotechnologyHealth CareTherapeutics